Patent ID: 7695722

Claim:
A method for decreasing cellular replication of ectodermally-derived, GnRH-receptor positive tumor cells in a subject, comprising: positively detecting and/or determining the presence of GnRH receptors and/or GnRH receptor concentration in the tumor cells, wherein the tumor cells are selected from the group consisting of lung- or neurally-derived oat-cell carcinoma cells and Kaposi sarcoma cells; and administering to said subject, a replication-decreasing amount of LHRH or a GnRH agonist selected from the group consisting of leuprorelin, triptorelin, buserelin, goserelin, nafarelin, and a pharmacologically acceptable salt of any thereof, which interacts with the GnRH receptor to thereby decrease the cellular replication of the oat-cell carcinoma cells or Kaposi sarcoma cells.